4basebio PLC (FRA:88Q)
Germany flag Germany · Delayed Price · Currency is EUR
6.15
0.00 (0.00%)
At close: Jan 30, 2026

4basebio Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1.780.930.510.270.340.46
Revenue Growth (YoY)
198.49%84.39%88.81%-20.71%-26.84%-42.82%
Cost of Revenue
0.680.30.170.030.070.19
Gross Profit
1.10.630.340.240.270.27
Selling, General & Admin
16.5213.878.813.881.860.66
Research & Development
---2.081.620.34
Other Operating Expenses
-0.1-0.44-0.31-0.060.32-0.1
Operating Expenses
16.4313.428.515.913.80.9
Operating Income
-15.33-12.79-8.17-5.67-3.53-0.62
Interest Expense
-0.83-0.75-0.3-0.09-0.11-0.09
Interest & Investment Income
0.670.14----
Currency Exchange Gain (Loss)
0.750.750.11-0.17--
EBT Excluding Unusual Items
-14.73-12.65-8.35-5.93-3.64-0.72
Pretax Income
-14.73-12.65-8.35-5.93-3.64-0.72
Income Tax Expense
-0.33-0.32-0.69-0.78-0.410
Net Income
-14.41-12.33-7.67-5.15-3.24-0.72
Net Income to Common
-14.41-12.33-7.67-5.15-3.24-0.72
Shares Outstanding (Basic)
15131212129
Shares Outstanding (Diluted)
15131212129
Shares Change (YoY)
15.92%6.47%0.01%-37.05%4.24%
EPS (Basic)
-0.99-0.94-0.62-0.42-0.26-0.08
EPS (Diluted)
-0.99-0.94-0.62-0.42-0.26-0.08
Free Cash Flow
-14.6-11.44-7.05-5.86-3.62-1.37
Free Cash Flow Per Share
-1.01-0.87-0.57-0.48-0.29-0.15
Gross Margin
61.55%67.52%67.19%89.18%79.59%59.31%
Operating Margin
-861.83%-1371.17%-1613.83%-2115.30%-1043.49%-134.63%
Profit Margin
-809.95%-1321.87%-1514.82%-1921.64%-957.10%-155.63%
Free Cash Flow Margin
-820.46%-1226.26%-1393.08%-2186.19%-1072.19%-297.19%
EBITDA
-14.7-12.04-7.6-5.33-3.35-0.58
EBITDA Margin
------125.54%
D&A For EBITDA
0.630.760.570.340.180.04
EBIT
-15.33-12.79-8.17-5.67-3.53-0.62
EBIT Margin
------134.63%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.